Aravt Global LLC Position in Cdk Global INC (CDK) Lowered by $11.21 Million as Valuation Declined

June 14, 2018 - By Duane Lopez

CDK Global, Inc. (NASDAQ:CDK) Logo

Aravt Global Llc decreased its stake in Cdk Global Inc (CDK) by 13.04% based on its latest 2018Q1 regulatory filing with the SEC. Aravt Global Llc sold 178,000 shares as the company’s stock declined 8.48% with the market. The institutional investor held 1.19 million shares of the miscellaneous company at the end of 2018Q1, valued at $75.19 million, down from 1.37 million at the end of the previous reported quarter. Aravt Global Llc who had been investing in Cdk Global Inc for a number of months, seems to be less bullish one the $8.67B market cap company. The stock increased 0.99% or $0.65 during the last trading session, reaching $65.85. About 623,433 shares traded. CDK Global, Inc. (NASDAQ:CDK) has risen 4.20% since June 14, 2017 and is uptrending. It has underperformed by 8.37% the S&P500.

Analysts await CDK Global, Inc. (NASDAQ:CDK) to report earnings on August, 7. They expect $0.82 earnings per share, up 49.09 % or $0.27 from last year’s $0.55 per share. CDK’s profit will be $107.91M for 20.08 P/E if the $0.82 EPS becomes a reality. After $0.85 actual earnings per share reported by CDK Global, Inc. for the previous quarter, Wall Street now forecasts -3.53 % negative EPS growth.

More news for CDK Global, Inc. (NASDAQ:CDK) were recently published by: Nasdaq.com, which released: “CDK Global Announces Pricing of its $500000000 5.875% Senior Notes Due 2026” on June 04, 2018. Globenewswire.com‘s article titled: “CDK Global Announces Proposed Registered Offering of Senior Notes” and published on June 04, 2018 is yet another important article.

CDK Global, Inc. (NASDAQ:CDK) Ratings Coverage

Among 3 analysts covering CDK Global (NASDAQ:CDK), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. CDK Global had 5 analyst reports since January 17, 2018 according to SRatingsIntel. Morgan Stanley maintained CDK Global, Inc. (NASDAQ:CDK) rating on Wednesday, January 31. Morgan Stanley has “Equal-Weight” rating and $77 target. Morgan Stanley maintained CDK Global, Inc. (NASDAQ:CDK) on Friday, April 27 with “Equal-Weight” rating. The stock has “Buy” rating by Wells Fargo on Wednesday, January 31. The firm has “Outperform” rating given on Tuesday, May 29 by Barrington Research. The company was downgraded on Wednesday, January 17 by Barrington Research.

CDK Global, Inc. (NASDAQ:CDK) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.